文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝硬化患者的神经胃肠病学与动力障碍

Neurogastroenterology and motility disorders in patients with cirrhosis.

作者信息

Idalsoaga Francisco, Ayares Gustavo, Blaney Hanna, Cabrera Daniel, Chahuan Javier, Monrroy Hugo, Matar Ayah, Halawi Houssam, Arrese Marco, Arab Juan Pablo, Díaz Luis Antonio

机构信息

Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile.

Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada.

出版信息

Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000622. eCollection 2025 Jan 1.


DOI:10.1097/HC9.0000000000000622
PMID:39773873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717532/
Abstract

Neurogastroenterology and motility disorders are complex gastrointestinal conditions that are prevalent worldwide, particularly affecting women and younger individuals. These conditions significantly impact the quality of life of people suffering from them. There is increasing evidence linking these disorders to cirrhosis, with a higher prevalence compared to the general population. However, the link between neurogastroenterology and motility disorders and cirrhosis remains unclear due to undefined mechanisms. In addition, managing these conditions in cirrhosis is often limited by the adverse effects of drugs commonly used for these disorders, presenting a significant clinical challenge in the routine management of patients with cirrhosis. This review delves into this connection, exploring potential pathophysiological links and clinical interventions between neurogastroenterology disorders and cirrhosis.

摘要

神经胃肠病学和动力障碍是复杂的胃肠道疾病,在全球范围内普遍存在,尤其影响女性和年轻人。这些疾病严重影响患者的生活质量。越来越多的证据表明这些疾病与肝硬化有关,其患病率高于普通人群。然而,由于机制尚不明确,神经胃肠病学和动力障碍与肝硬化之间的联系仍不清楚。此外,在肝硬化患者中管理这些疾病通常受到常用于治疗这些疾病的药物的不良反应的限制,这在肝硬化患者的常规管理中带来了重大的临床挑战。本综述深入探讨了这种联系,探索神经胃肠病学疾病与肝硬化之间潜在的病理生理联系和临床干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/7056e6fdfd45/hc9-9-e0622-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/bc936ef3ed0d/hc9-9-e0622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/be4086dc9f73/hc9-9-e0622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/7056e6fdfd45/hc9-9-e0622-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/bc936ef3ed0d/hc9-9-e0622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/be4086dc9f73/hc9-9-e0622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e295/11717532/7056e6fdfd45/hc9-9-e0622-g003.jpg

相似文献

[1]
Neurogastroenterology and motility disorders in patients with cirrhosis.

Hepatol Commun. 2025-1-7

[2]
[The influence of splenic artery ligature on the severity of portal gastropathy in patients with hepatic cirrhosis].

Klin Khir. 2003-10

[3]
Overview of neurogastroenterology-gastrointestinal motility and functional GI disorders: classification, prevalence, and epidemiology.

Gastroenterol Clin North Am. 2007-9

[4]
From the bench to the 'crib'-side: implications of scientific advances to paediatric neurogastroenterology and motility.

Neurogastroenterol Motil. 2006-4

[5]
Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review.

Neurogastroenterol Motil. 2024-5

[6]
Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.

J Clin Invest. 2013-10-1

[7]
Neurogastroenterology in 2011: Emerging concepts in neurogastroenterology and motility.

Nat Rev Gastroenterol Hepatol. 2011-12-13

[8]
Pediatric to adult transition care in neurogastroenterology and motility: A position paper from the American Neurogastroenterology and Motility Society and European Society of Neurogastroenterology and Motility.

Neurogastroenterol Motil. 2024-10

[9]
Review article: Oesophageal disorders in chronic liver disease.

Aliment Pharmacol Ther. 2024-9

[10]
"An urgent need for transition of care programs for adolescents and young adults with neurogastroenterology and motility disorders".

J Pediatr Gastroenterol Nutr. 2024-7

本文引用的文献

[1]
Prevalence of Belching Disorders and Their Characteristics in the General Adult Population.

Am J Gastroenterol. 2024-12-1

[2]
Review article: Oesophageal disorders in chronic liver disease.

Aliment Pharmacol Ther. 2024-9

[3]
Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis.

Hepatol Commun. 2024-8-1

[4]
Global prevalence of functional dyspepsia according to Rome criteria, 1990-2020: a systematic review and meta-analysis.

Sci Rep. 2024-2-20

[5]
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet. 2023-11-11

[6]
Lactulose in cirrhosis: Current understanding of efficacy, mechanism, and practical considerations.

Hepatol Commun. 2023-11-1

[7]
Safe Use of POEM in a Patient With Decompensated Cirrhosis and Severe Achalasia.

ACG Case Rep J. 2023-9-23

[8]
Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review.

World J Hepatol. 2023-7-27

[9]
Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment.

World J Gastroenterol. 2023-7-14

[10]
The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.

Sci Rep. 2023-5-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索